ECM
AVEO

Element Capital Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Element Capital Management’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-13,373
Closed -$388K – 1089
2018
Q1 		$388K Buy
+13,373
New +$391K 0.01% 375

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Element Capital Management's AVEO Position: Q2 2018 in Review

Element Capital Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q2 2018, closing a stake of 13,373 shares — an estimated $388K sold.

Element Capital Management first reported a position in AVEO in Q1 2018 and held it in 1 quarter. The position peaked at $388K in Q1 2018. 94 funds tracked by Wall St. Rank hold AVEO as of Q2 2018.

  • Element Capital Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
  • Element Capital Management sold 13,373 AVEO Pharmaceuticals, Inc. shares in Q2 2018, an estimated $388K.
  • Element Capital Management first reported a position in AVEO Pharmaceuticals, Inc. in Q1 2018 and held it in 1 quarter.
  • Element Capital Management's AVEO Pharmaceuticals, Inc. position peaked at $388K in Q1 2018.
  • 94 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q2 2018.

Based on Element Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.